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Abstract
Background: The epicardium, a cell layer covering the heart, plays an important role during cardiogenesis
providing cardiovascular cell types and instructive signals, but becomes quiescent during adulthood. Upon cardiac
injury the epicardium is activated, which includes induction of a developmental gene program, epithelial-to-
mesenchymal transition (EMT) and migration. However, the response of the adult epicardium is suboptimal
compared to the active contribution of the fetal epicardium to heart development. To understand the therapeutic
value of epicardial-derived cells (EPDCs), a direct comparison of fetal and adult sources is paramount. Such analysis
has been hampered by the lack of appropriate culture systems.
Methods: Human fetal and adult EPDCs were isolated from cardiac specimens obtained after informed consent.
EPDCs were cultured in the presence of an inhibitor of the TGFβ receptor ALK5. EMT was induced by stimulation
with 1 ng/ml TGFβ. PCR, immunofluorescent staining, scratch assay, tube formation assay and RT2-PCR for human
EMT genes were performed to functionally characterize and compare fetal and adult EPDCs.
Results: In this study, a novel protocol is presented that allows efficient isolation of human EPDCs from fetal and
adult heart tissue. In vitro, EPDCs maintain epithelial characteristics and undergo EMT upon TGFβ stimulation.
Although similar in several aspects, we observed important differences between fetal and adult EPDCs. Fetal and
adult cells display equal migration abilities in their epithelial state. However, while TGFβ stimulation enhanced adult
EPDC migration, it resulted in a reduced migration in fetal EPDCs. Matrigel assays revealed the ability of adult
EPDCs to form tube-like structures, which was absent in fetal cells. Furthermore, we observed that fetal cells
progress through EMT faster and undergo spontaneous EMT when TGFβ signaling is not suppressed, indicating that
fetal EPDCs more rapidly respond to environmental changes.
Conclusions: Our data suggest that fetal and adult EPDCs are in a different state of activation and that their
phenotypic plasticity is determined by this activation state. This culture system allows us to establish the cues that
determine epicardial activation, behavior, and plasticity and thereby optimize the adult response post-injury.
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Background
Although the epicardium is merely a cell layer covering
the myocardium, it is increasingly gaining interest due
to its contribution to cardiac development, as well as its
potential role in cardiac repair.
The epicardium derives from the proepicardial organ,
a transient structure located at the base of the heart
from where cells migrate to ultimately envelop the
developing myocardium. Subsequently, a subset of
epicardial cells undergo epithelial-to-mesenchymal tran-
sition (EMT), thereby forming epicardial-derived cells
(EPDCs) that migrate into the subepicardial space [1, 2].
EPDCs impact on heart development by differentiating
into several cardiac cell lineages, including fibroblasts,
vascular smooth muscle cells (reviewed in [3]) and,
potentially into coronary endothelial cells and cardio-
myocytes [4–6]. Moreover, the remaining fetal epicardial
layer produces growth factors and cytokines that support
the growth of the underlying myocardium [7]. The im-
portance of the epicardium in heart development is
underscored by the finding that disrupting its proper
formation results in a hypoplastic myocardium [8–10].
Furthermore, blocking epicardial migration into the
myocardium during development leads to dysmorphic
hearts, including absence of the apex and reduction of
myocardial thickness [11].
In contrast, in the healthy adult heart, the epicardium
is a quiescent layer. However following cardiac injury,
epicardial cells are re-activated, which includes upregula-
tion of a developmental gene program, including the
embryonic epicardial genes Wilms’ tumor 1 (Wt1) and T
box 18 (Tbx18) [12–14]. Subsequently, as part of their
cellular activation, the epicardial layer expands and cells
undergo EMT upon which they migrate into the under-
lying tissue. Here they contribute to the endogenous car-
diac repair mechanisms including scar formation, and
possibly cardiac regeneration (reviewed in [15, 16]). The
significance of epicardial activation in the adult is shown
by the fact that preventing EMT and epicardial expan-
sion post-injury leads to impaired cardiac function [17].
Conversely, when the heart is primed via intraperitoneal
injection of Thymosin β4 prior to injury, epicardial acti-
vation is increased. This resulted in an improved epicar-
dial response, enhanced cardiac output and reduced
infarct size [13]. Altogether this shows the importance
of epicardial activation and the important role the epi-
cardium has and could have as a myocardial support
mechanism following injury.
Given the activation of a developmental program upon
injury, a thorough understanding of fetal EPDC behavior
is crucial to appreciate the epicardial potential in cardiac
repair. To date the intrinsic behavior of fetal and adult
EPDCs has not been compared. Such comparison could
provide insight into the factors and pathways that
determine the optimal epicardial response observed in
cardiac development. This knowledge could then be ap-
plied to the adult epicardium to enhance the epicardial
activation response post-injury. To this end, in vitro
models would be indispensable for epicardial research.
However, one of the major obstacles has been the inabil-
ity to consistently isolate a pure population of EPDCs
from both fetal and adult heart tissue, and maintain
these cells in a stable epithelial state in vitro.
In the present study, we describe a novel method for
the isolation and expansion of EPDCs derived from fetal
and adult human heart tissue. We show that cells from
both sources can maintain an epicardial phenotype in
culture, and participate in several processes related to in
vivo EPDC behavior, including EMT and migration. Al-
though similar in many aspects, our culture model re-
vealed that there are important differences between fetal
and adult EPDCs. These differences are likely related to
our observation that fetal EPDCs respond faster to
EMT-inducing cues. Therefore, we propose that fetal
and adult EPDCs are present in different stages of acti-
vation. Our culture system will prove to be a useful tool
to investigate the process of activation in both cell
sources and therefore open new avenues in understand-
ing the full epicardial potential for cardiac repair.
Methods
Human cardiac tissue collection
Human fetal hearts, aged between 10 to 22 weeks post
gestation, were collected after elective abortion without
medical indication and based on individual informed
consent. Adult human atrial samples (auricles) were ob-
tained during cardiac surgery. These specimens are ob-
tained as redundant material during right atrial
cannulation for extracorporeal bypass and were anonym-
ously collected as surgical waste under general informed
consent. Experiments were performed using both male
and female samples and were carried out according to
the official guidelines of the Leiden University Medical
Center and approved by the local Medical Ethics Com-
mittee. This research conforms to the Declaration of
Helsinki.
Isolation and culture conditions of human EPDCs
Fetal and adult EPDCs were isolated by separating the
epicardium from the underlying myocardium. The tissue
was processed into small pieces and digested during
three rounds of Trypsin 0.25%/EDTA incubation (1:1;
Serva and USH products) for a total of 30 minutes at
37 °C. The suspension was subsequently passed through
a series of syringes of decreasing size (19G to 22G). The
cell suspension was passed through a 100-μm cell
strainer (BD Falcon, Franklin Lakes, NJ, USA), collected
and plated on 0.1% gelatin-coated dishes (Sigma-Aldrich,
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St. Louis, MO, USA). The established EPDCs were cul-
tured in a mixture of 1:1 Dulbecco’s modified Eagle’s
medium (DMEM-glucose low; Invitrogen, Carlsbad, CA,
USA) and Medium 199 (M199; Invitrogen) supple-
mented with 10% heat-inactivated fetal calf serum (FCS;
Gibco, Carlsbad, CA, USA), and 100 U/ml penicillin/
streptomycin (Gibco). To maintain cells in an epithelial
state, the ALK5-kinase inhibitor SB431542 (5–10 μm;
Tocris Bioscience, Ellisville, MO, USA) was added. In
experiments aimed at inducing EMT, cells were stimu-
lated with 1 ng/ml transforming growth factor beta 3
(TGFβ3), without SB, for 4 days. EPDCs used in experi-
ments did not exceed ten passages.
mRNA isolation and quantitative RT-PCR
Total RNA was isolated using Tripure (Roche, Basel,
Switzerland) according to the manufacturer’s protocol.
Samples were treated with recombinant DNAseI (Roche)
followed by cDNA synthesis using the Revert Aid H
minus First Strand Synthesis Kit with OligodT primers
(Thermo Fisher Scientific, Waltham, MA, USA); both
according to the manufacturers’ recommendations. Sub-
sequently, qRT-PCR was performed using SYBR Green
(Bio-Rad Laboratories, Hercules, CA, USA) and run on
a CFX Connect Real-Time System (Bio-Rad). For
visualization purposes, samples were run for 35 cycles
and processed on a 3% agarose gel. Primer sequences
are available upon request.
EMT PCR array
Fetal and adult cell isolations (three independent isola-
tions for each source) were cultured in either SB431542,
TGFβ3 or empty medium for 4 days. RNA was isolated
using the NucleoSpin® columns (Macherey-Nagel,
Düren, Germany) according to the manufacturer’s in-
structions. Subsequently, cDNA was synthesized using
the RT2 First Strand Kit (SA Biosciences, Valencia, CA,
USA). A RT2 profiler array was performed for EMT-
related genes (type PAHS-090Z from SA Biosciences)
using SYBR® Green qPCR Mastermix (SA Biosciences).
Hierarchical cluster analysis was performed using
Matlab (The MathWorks, Inc., Natick, MA, USA; ver-
sion 2016a).
Immunohistochemistry
Cells were fixed in 4% paraformaldehyde and perme-
abilized using PBS/0.25% Triton X100. Samples were
blocked in 5% FCS in PBS or 10% FCS/0.1% Triton X-
100 in PBS for 15 minutes and subsequently incubated
overnight at 4 °C with primary antibody. Antibodies
were diluted 1:100 in blocking buffer and directed
against WT1 (Abcam, Cambridge, MA, USA), TBX18
(Sigma-Aldrich), TCF21 (Santa Cruz Technologies, Dal-
las, TX, USA), ZO-1 (Life Technologies, Carlsbad, CA,
USA), αSMA (Sigma-Aldrich), PECAM1 (Santa Cruz
Technologies) and vimentin (Cell Signaling, Danvers,
MA, USA). Alexa Fluor® 488- and 555-conjugated
secondary antibodies (Invitrogen) were used at a 1:250
dilution. Phalloidin, conjugated to Alexa Fluor® 488, was
applied at a 1:250 dilution. Slides were mounted with
Prolong Gold containing DAPI (Invitrogen). All pictures
were handled in an equal fashion.
Scratch assay
Scratch assays were performed by plating EPDCs in 48-
well plates (in growth medium). Cells were grown to a
nearly confluent monolayer, and subsequently cultured
for 48 hours in the presence or absence of SB431542, or
stimulated with 1 ng/ml TGFβ3 to induce partial EMT.
The scratch was created as previously described [18]
without changing medium. Cells were subsequently
monitored for 12 hours, taking pictures every 4 hours.
The percentage gap closure was measured using Matlab
(version 2016a).
Matrigel assay
Five thousand EPDCs were resuspended in growth
medium containing 25 ng/ml VEGF (Peprotech, Rocky
Hill, NJ, USA) and seeded onto Matrigel™-coated (BD
Bioscience, San Diego, CA, USA) 96-well plates. After
24 hours the formation of tubes was measured using the
Angiogenesis Analyzer plugin for ImageJ (developed by
Gilles Carpentier).
Statistics
Graphs are represented as mean ± SD of at least three
independent experiments (unless otherwise indicated).
Fetal and adult samples were compared using an un-
paired Student’s t test. A paired Student’s t test was used
when different stimulations were applied to the same
EPDC culture. Significance was assumed when p < 0.05.
GraphPad Prism (GraphPad Software, San Diego, CA,
USA; version 6) was used for statistical analysis.
Results
Fetal and adult human EPDCs maintain their epicardial
character in vitro
The epicardium is located directly on the myocardium
and can be separated from the underlying tissue using
forceps (Additional file 1: Figure S1a). We confirmed the
epicardial identity of the isolated layer by qRT-PCR. The
epicardial marker WT1 was expressed, while no expres-
sion of the mesenchymal marker alpha-smooth muscle
actin (αSMA) or the cardiomyocyte markers beta-myosin
heavy chain (βMHC), cardiac troponin T (cTnT) and car-
diac-actin (cActin) was observed (Additional file 1: Fig-
ure S1b and data not shown). This validated that we
exclusively isolated the epicardium.
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Primary cell cultures of both fetal and adult EPDCs
were established by generating a single-cell suspension
from the epicardial layer. The cells were cultured in
medium containing SB431542 (SB) which is a selective
inhibitor of the activin receptor-like kinase (ALK5), a
type I receptor of transforming growth factor beta
(TGFβ). Using this approach, isolated EPDCs could be
maintained and expanded in culture as a monolayer of
epithelial cells, while maintaining their characteristic
cobblestone morphology (Fig. 1a).
To determine if cultured human EPDCs maintained
their epicardial signature in vitro, their gene expression
pattern was assessed. The common epicardial marker
transcripts WT1, TBX18, aldehyde dehydrogenase 1 fam-
ily member A2 (ALDH1A2) and transcription factor 21
(TCF21) [11, 12, 19–21] were present in both fetal and
adult EPDCs as shown in Fig. 1b. In addition, several
other epicardial genes, like basonuclin 1 (BNC1) and
keratin 8 (KRT8), that were found enriched in the devel-
oping epicardium [22], were present in both populations
(Fig. 1b and Additional file 1: Figure S2a). Furthermore,
transcripts that were previously reported to be present
in EPDCs or epithelial cells [22–28] were analyzed and
found to be present. Their expression is summarized in
Additional file 1: Figure S2a. Immunofluorescent analysis
confirmed the presence (Fig. 1c) and nuclear localization
(Additional file 1: Figure S2b-d) of the proteins and epi-
cardial transcription factors WT1, TBX18, and TCF21.
Moreover, the isolated fetal and adult EPDCs formed
tight junctions, demonstrated by the presence of zona
occludens-1 (ZO-1) at their cell borders (Fig. 1d).
Taken together, these data show that the epicardial
layer can be successfully isolated from human fetal and
adult heart tissue. The derived EPDCs are of epicardial
origin, and maintain their epicardial characteristics in
culture.
Cultured EPDCs do not display markers of other
heart-resident cell types
To verify further that we indeed obtained human epicar-
dial cells, we aimed to exclude potential contamination
of our cultures with other cardiac cell types. Both fetal
(Fig. 2a) and adult derived cells (Fig. 2b) did not express
αSMA. In addition, expression of the mesenchymal tran-
script periostin (POSTN) was low (Additional file 1:
Figure S3a-b). Since endothelial cells have a comparable
cobblestone phenotype, we examined the expression of
platelet-endothelial cell adhesion molecule 1 (PECAM1)
by immunofluorescent analysis, and found it to be ab-
sent (Fig. 2c). qRT-PCR corroborated the absence of
PECAM1 and VE-cadherin (CDH5; Additional file 1:
Figure S3c). Furthermore, mRNAs encoding markers at-
tributed to the endocardium, cardiac progenitor cells,
hematopoietic system, and cardiomyocytes were not
present (Fig. 2d and Additional file 1: Figure S3d–g).
Fig. 1 Human fetal and adult EPDCs express epicardial markers in culture. a Isolated fetal and adult EPDCs displayed a cobblestone appearance
indicative of their epithelial phenotype (scale bar: 100 μm). b The presence of several epicardial markers was confirmed by PCR. Shown are two
independently isolated fetal (F) and adult (A) EPDC cultures. Total adult myocardium, without epicardium, was used as negative control (-) and
non-cultured epicardium as positive control (+). c Immunofluorescent staining showed that both EPDC populations were positive for the
transcription factors WT1, TBX18 and TCF21 (scale bars: 100 μm). d ZO-1 depicted the tight junctions substantiating their epithelial phenotype
(scale bar: 20 μm). EPDCs epicardial-derived cells
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Overall, we show that both fetal and adult EPDCs
could be distinguished from the myocardial and endo-
cardial lineage as well as from other heart-resident cell
types.
Fetal and adult human EPDCs undergo EMT upon TGFβ
stimulation
EMT is fundamental to formation of the heart during
development and repair following injury [29]. EMT is a
gradual process during which epithelial cells lose cell-
cell contact and their epithelial morphology changes into
a mesenchymal elongated phenotype. TGFβ has been
shown to play a pivotal role in inducing EMT in for ex-
ample proepicardial cells [30] and human adult EPDCs
leading to, among others, downregulation of WT1 [27].
We compared the ability of fetal and adult EPDCs to
respond to TGFβ and undergo EMT. Four days after
TGFβ stimulation, both fetal and adult EPDCs lost their
characteristic cobblestone morphology and transformed
into elongated spindle-shaped cells, indicators of a mes-
enchymal phenotype (Fig. 3a). Besides a morphological
change, we confirmed the occurrence of EMT by im-
munofluorescent analysis and qRT-PCR. A decrease in
nuclear WT1 expression levels in both fetal and adult
cells was observed (Fig. 3b), as well as an increase in
αSMA expression (Fig. 3c). In addition, in EPDCs
phalloidin-labeled F-actin was predominantly organized
in cortical bundles located at the cell surface, while this
expression pattern changed into stress fibers that
traversed the cells upon TGFβ stimulation (Fig. 3d).
Concurrently, the mesenchymal marker vimentin (VIM)
showed an increase in organized networks of intermedi-
ate filaments after stimulation (Fig. 3e). A decline in
mRNA expression of ALDH1A2 and the epithelial
marker E-cadherin (CDH1) was observed in fetal and
adult EPDCs (Additional file 1: Figure S4a-b). In
addition, upregulation of POSTN and fibronectin 1
(FN1) illustrated their transition toward a mesenchymal
cell fate (Additional file 1: Figure S4c-d). In summary,
these data show that fetal and adult EPDCs have the
ability to undergo EMT upon TGFβ stimulation.
Fetal and adult EPDCs have a different migration ability
upon TGFβ stimulation
In vivo, both during development as well as after injury,
induction of EMT in epicardial cells is followed by
Fig. 2 Cultured EPDCs do not display markers of other heart-resident cell types. Immunofluorescent staining confirmed the absence of αSMA in
both (a) fetal and (b) adult EPDCs, using mesenchymal cells as positive control (scale bar: 50 μm). c EPDCs were negative for the endothelial
marker PECAM1 (scale bar: 50 μm). Human umbilical vein endothelial cells (HUVECs) were used as positive control. d qRT-PCR analysis confirmed
the absence of markers attributed to cardiac progenitor cells, the endocardium, hematopoietic system, and myocardium. EPDCs
epicardial-derived cells
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migration of these cells into the underlying tissue. To
determine whether cultured fetal and adult EPDCs
retained this ability, we assessed their functional migra-
tion by performing scratch assays.
As typical for epithelial cells [31], both fetal and adult
EPDCs migrated as a sheet of cells upon closure of the
artificial wound (Fig. 4a). Analyzing the percentage of
closure after 12 hours showed that in the presence of
SB, fetal and adult EPDCs had an equal migratory ability
(around 70% closure in Fig. 4b-c). Cellular migration is
known to be increased upon the induction of EMT [32].
Therefore, we hypothesized that TGFβ would increase
the mobility of EPDCs. As expected, a 2-day stimulation
with TGFβ, thereby partially inducing EMT, resulted in
an increased migration of adult EPDCs (Fig. 4c). Strik-
ingly, fetal EPDCs responded to TGFβ by decreasing
their motility (Fig. 4b). These results confirmed that in
vitro EPDCs retained their ability to migrate. Further-
more, it suggests that fetal EPDCs are in a different
epithelial activation state, as their migration rate upon
TGFβ stimulation resembles the speed of their fully dif-
ferentiated mesenchymal descendants (as evident from
Additional file 1: Figure S5a). Mesenchymal EPDCs are
hereafter referred to as spindle-shaped EPDCs (sEPDCs).
The transition into a mesenchymal phenotype has
generally been associated with the gain of migratory
properties [31]. Interestingly however, fetal and adult
sEPDCs displayed a lower migration capacity com-
pared to their epithelial counterparts (Additional file 1:
Figure S5a-b). This shows that EMT is not a linear process
and cells can acquire migratory properties while still
present in their epithelial state, a feature which was previ-
ously shown for the mammary epithelium [33].
Fetal and adult human EPDCs behave differently in tube
formation assay
EPDCs have been suggested to participate in the forma-
tion of coronary vessels [4, 5, 21, 34]. Therefore, we
assessed the ability of fetal and adult EPDCs to form a
network in a Matrigel-based tube formation assay.
Fig. 3 Human fetal and adult EPDCs undergo EMT upon TGFβ stimulation. a Phase contrast microscopy showed that SB-treated cells displayed a
characteristic cobblestone morphology, while upon TGFβ stimulation both fetal and adult EPDCs underwent EMT. This was evident by transformation
into a spindle-shaped and elongated morphology. Change in morphology was accompanied by (b) a decrease in nuclear WT1 and (c) an increase in
αSMA. Upon TGFβ stimulation, (d) phalloidin visualized the increase in actin filaments and (e) VIM staining showed an organized network of intermediate
filaments (scale bars: 100 μm). EPDCs epicardial-derived cells, SB medium containing SB431542, TGFβ transforming growth factor beta
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Interestingly, only adult EPDCs were able to form an
αSMA+ tubular network, while fetal EPDCs failed to do
so (Fig. 5a–c). A similar trend was observed for mesen-
chymal EPDCs, showing an increased ability of adult
sEPDCs to form tubes compared to fetal sEPDCs (Fig. 5d
and Additional file 1: Figure S5c).
Since only adult EPDCs were able to assemble into a
tubular network, we questioned whether partial induc-
tion of EMT in adult EPDCs would enhance their angio-
genic activity, like it increased their migration rate.
Therefore, we compared SB-treated cells with their non-
treated and TGFβ-stimulated counterparts. Removal of
SB and pretreatment with TGFβ increased the vascular
potential of adult EPDCs (Additional file 1: Figure S5d).
The inability of fetal cells to form networks suggests
that fetal and adult EPDCs have different intrinsic abil-
ities. Interestingly, qRT-PCR analysis for the kinase
insert domain receptor (KDR or VEGFR2) revealed that
its expression level is higher in adult EPDCs compared
to fetal EPDCs (data not shown), and might explain
why fetal EPDCs fail to develop tubular structures.
Furthermore, taking together our observations from
the migration and tube formation assay, our data in-
dicate that partial induction of EMT by TGFβ stimu-
lation increases the ability of adult EPDCs to migrate
and form a tubular network. This suggests that adult
EPDCs can be present in different stages of epithelial
activation and that their cell fate potential is deter-
mined by this activation state.
Human fetal EPDCs are more prone to undergo EMT
Removing cells from their natural in vivo environment
into a cell culture situation may potentially result in the
induction of EMT. We routinely added the ALK5 kinase
inhibitor SB to maintain EPDCs in their epithelial state
and prevent the induction of EMT through (endogenous)
TGFβ. Thus far, fetal and adult EPDCs cultured under
these conditions appeared quite similar with respect to
their morphology, expression of epicardial genes, as well
as their ability to undergo EMTand migrate. Interestingly,
we observed that adult EPDCs relied less on the presence
of SB and retained their cobblestone phenotype even
when this inhibitor was removed (Fig. 6a). The epithelial
nature of fetal EPDCs, on the other hand, was highly
dependent on the presence of the ALK5 inhibitor (SB)
during culture. Upon removal of SB, fetal EPDCs rapidly
underwent spontaneous EMT, demonstrated by their
morphological change towards a mesenchymal phenotype
(Fig. 6a), withdrawal of WT1 from the nucleus (Additional
file 1: Figure S6a) and upregulation of αSMA filaments
(Fig. 6a). Furthermore, fetal EPDCs underwent TGFβ-
induced EMT at a faster rate, compared to adult EPDCs.
In fetal cultures, αSMA+ cells were observed after
Fig. 4 Fetal and adult EPDCs have a different migration ability upon
TGFβ stimulation. a In a scratch assay, both fetal and adult EPDCs
closed the gap as a sheet of cells (scale bar: 100 μm). Quantification
of the migration rate after 12 hours showed that, (b) upon TGFβ
stimulation and thereby partial induction of EMT, the percentage
closure decreased for fetal EPDCs (paired t test). On the other hand,
(c) adult EPDCs closed the gap faster upon TGFβ stimulation (paired
t test). The different colors represent the different donors, for both
fetal and adult cultures. #p < 0.05. EPDCs epicardial-derived cells, SB
medium containing SB431542, TGFβ transforming growth factor beta
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Fig. 5 Fetal and adult EPDCs behave differently in tube formation assay. a Matrigel-based tube formation assay revealed that fetal EPDCs and
sEPDCs failed to form tubes. In contrast, both adult EPDCs and sEPDCs were able to assemble in a network of tube-like structures. b Tubes
expressed αSMA (scale bars: 100 μm). Tube formation is displayed as average length of tubes for (c) fetal and adult EPDCs and (d) their fully
differentiated mesenchymal counterparts (sEPDCs). #p < 0.05. EPDCs epicardial-derived cells, sEPDCs spindle-shaped epicardial-derived cells
Fig. 6 Human fetal EPDCs are more prone to undergo EMT. a Upon removal of SB from culture medium, adult EPDCs remained their epithelial
character while fetal EPDCs underwent EMT. This was evident by the change in morphology, decrease in nuclear WT1 and increase in αSMA
staining (scale bars: 100 μm; staining intensity was corrected to their corresponding SB control). b An EMT-PCR array was performed for SB,
non- (empty) and TGFβ -stimulated EPDCs and visualized as clustergram using Ward’s linkage. Upon hierarchical clustering, unstimulated adult
EPDCs (empty) were closely related to their SB control, while unstimulated fetal EPDCs clustered together with their TGFβ-treated condition.
EPDCs epicardial-derived cells, SB medium containing SB431542, TGFβ transforming growth factor beta
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24 hours of TGFβ stimulation while for adult cultures this
took more than 48 hours (Additional file 1: Figure S6b).
To further verify whether fetal EPDCs indeed respond
faster to EMT-related cues, we performed a PCR array
for EMT-related genes. Fetal and adult EPDCs were cul-
tured in empty, SB- or TGFβ-containing medium for
4 days. Interestingly, upon hierarchical clustering using
Ward’s linkage, non-treated (empty) cells clustered to-
gether with SB-treated cells in the adult setting, while
the empty condition in fetal cells resembled TGFβ-
stimulated cells (Fig. 6b). This pattern was independent
of the linkage method used and was consistently ob-
served performing average, single, complete, centroid
and median linkage (data not shown). The PCR array
shows that fetal EPDCs, upon SB removal, became more
closely related to their spindle-shaped descendants in
comparison to adult EPDCs. Interestingly, when com-
paring gene expression between fetal and adult EPDCs,
we observed a baseline difference in several EMT-related
genes. CDH1 and annexin A8 (ANXA8), genes related to
(quiescent) epithelium, are expressed at lower levels in
fetal cells (Additional file 1: Figure S6c), while the mes-
enchymal genes TCF21 and VIM were significantly up-
regulated in fetal EPDCs (Additional file 1: Figure S6d).
Although VIM was highly expressed in fetal EPDCs it
did not organize in filaments characteristic for mesen-
chymal cells (Fig. 3e). Altogether this suggests that fetal
EPDCs are more prone to undergo EMT. Furthermore,
it shows that fetal epithelial EPDCs, in contrast to adult
EPDCs, already have a mesenchymal signature, suggest-
ing that they have the intrinsic ability to undergo EMT.
Discussion
Since the epicardium envelopes the myocardium, it is
relatively easily accessible and it could therefore repre-
sent a therapeutic target to facilitate cardiac repair. In
this context, EPDCs are an interesting endogenous cell
source to modulate scar formation and improve cardiac
regeneration [16, 35]. The post-myocardial infarction
(MI) response of the adult epicardium is suboptimal
compared to the active contribution of the fetal epicar-
dium during development. Furthermore, it is unknown
whether activation of the epicardium in the embryo can
be extrapolated to the adult setting. Therefore, it is para-
mount to directly compare fetal and adult EPDCs in
order to understand and increase the regenerative and
cardiac repair potential of human (adult) EPDCs. How-
ever, this has been hampered by the lack of suitable cul-
ture protocols.
With the method described in this article, we can now
efficiently isolate, expand, and maintain EPDCs derived
from adult and fetal human hearts. We have extensively
characterized these cells and confirmed their epicardial
status. A direct comparison revealed that fetal and adult
EPDCs both undergo TGFβ-induced EMT. Although
many functional aspects in these cells are similar, we
observed several differences that could be related to a
different stage of activation. A few protocols for the iso-
lation of EPDCs from mouse and human heart tissue
[23, 36–39] as well as from the mouse proepicardium
[40] have been reported. However, none of these proto-
cols describe the isolation and subsequent expansion of
the fetal and adult human epicardium using the same
method and culture conditions. Zhou et al. [39, 41] pre-
sented the isolation of mouse EPDCs from both the fetal
and adult epicardium using WT1-driven GFP expression
to sort EPDCs from a single-cell suspension. Since it is
based on reporter gene expression, it is impossible to
translate it into a human setting. General isolation based
on WT1 antibody binding is not feasible since we found
that this protein is also expressed by endothelial cells
[42]. More importantly, it is necessary to induce injury
to reactivate WT1 expression as it is absent in the adult
epicardium [14], which makes it impossible to study
adult EPDCs beyond the context of MI.
Assays based on explant outgrowth (including [38, 43,
44]) rely on migration of cells away from the cultured
heart tissue. This will promote EMT and onset of mes-
enchymal differentiation. For the adult mouse heart, it is
difficult to separate the epicardium from the myocar-
dium. Therefore isolation of mouse EPDCs relies on
explant outgrowth methods. However, outgrowth is not
always achieved without the addition of an inducer of
migration [45]. For fetal heart tissue, this method results
in a limited surface area of cell outgrowth and only a
part of the outgrown fetal EPDCs remain in an epithelial
state. This is most likely related to our observation that
fetal cells are more sensitive to EMT-inducing factors.
Importantly, using the outgrowth method to derive fetal
and adult cells, but also the WT1-based isolated EPDCs,
may represent a selection or subpopulation of epicardial
cells.
Protocols have also been developed for the differenti-
ation of EPDCs from human induced pluripotent stem
(iPS) cells [46, 47]. However, since it is difficult to fully
control the state of the iPS cell-derived EPDCs (fetal- or
adult-like), they do not provide the opportunity to com-
pare behavior of the developing and adult epicardium.
In vivo the epicardium is a heterogeneous population,
with cells existing in several degrees of activation both
during development, as upon reactivation in adulthood
[4, 11, 26]. Our protocol enabled us to maintain fetal
and adult EPDCs in an epithelial state with an epicardial
signature for several passages. However, whilst being
quiescent in vivo, the fact that the cells are dividing and
express WT1 in culture indicates that they are slightly
activated. When comparing EPDCs at baseline, subtle
differences between fetal- and adult-derived cells were
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observed. For instance, the enhanced expression of
ANXA8 and higher levels of CDH1 in adult EPDCs
could imply a more epithelial phenotype. Interestingly,
WT1 mutant epicardium was shown to have increased
levels of CDH1, which concurred with reduced epicar-
dial EMT and a lower expression of the mesenchymal
marker VIM [1]. Furthermore, the expression of TCF21,
which has been shown to play a role in cardiac fibroblast
specification [11], was upregulated in fetal EPDCs sug-
gesting that these cells are already partly committed to
the mesenchymal lineage.
The distinction between fetal and adult cells became
more obvious in the functional assays. Both fetal and
adult EPDCs migrated at similar speeds at baseline.
TGFβ has been shown to activate an epicardial motile
gene program [48]. Indeed, short-term TGFβ stimulation
increased the migration of adult EPDCs. In contrast, in
fetal EPDCs addition of TGFβ resulted in a significantly
delayed migration, whereby they resembled the migra-
tion speed of both fetal and adult sEPDCs. In addition
to increased migration, induction of EMT with TGFβ
stimulation increased the tube formation ability of adult
EPDCs. Altogether, this suggests that fetal and adult
EPDCs are in a different stage of epithelial activation
and shows that the EPDC cell fate potential is deter-
mined by its state of activation.
The concept that fetal EPDCs are in a different state
of activation, was strengthened by our observation that
fetal EPDCs respond faster to external cues like TGFβ
stimulation. Furthermore, fetal EPDCs are more
dependent on SB for their cobblestone morphology than
their adult counterparts. This could indicate that fetal
cells have a higher intrinsic and/or autocrine ability to
undergo EMT. This hypothesis is similar to what is seen
in embryonic endothelial cells which partly via autocrine
signaling underwent mesenchymal transformation,
thereby contributing to cushion formation [49].
Another potential explanation for this spontaneous
EMT could be that fetal EPDCs are mostly ventricular
while adult EPDCs are derived from the atrial epicar-
dium. Using an explant culture method, Risebro et al.
[50] showed that embryonic ventricular EPDCs spontan-
eously undergo EMT while atrium-derived embryonic
EPDC remain their epithelial phenotype. However, we
were able to derive epithelial EPDCs from both the de-
veloping atrium as well as the ventricle (data not
shown). This suggests that, at the developmental stages
we have studied, epicardial activation is independent of
the anatomic location of the epicardium along the car-
diac outline.
Taken together, our data suggest that adult EPDCs
exist in culture in an epithelial state, and require more
time and external cues to obtain mesenchymal proper-
ties. Fetal EPDCs are more mesenchymal in vitro and
therefore likely much more prone to undergo EMT. The
question remains whether adult EPDCs have lost this
feature, and if it could be reestablished provided the
right cues are present.
Conclusions
In conclusion, our primary EPDC cultures will provide
important knowledge regarding the human epicardial ac-
tivation process and epicardial behavior during develop-
ment and adult life. It provides the opportunity to
identify factors that are involved in EMT, migration, and
differentiation of human EPDCs. Furthermore, it will
give us insight into their signaling pathway sensitivity,
paracrine signals, and differentiation capabilities. More
importantly, this model allows the direct comparison be-
tween fetal and adult EPDCs, which will be important
given the embryonic activation response of the epicar-
dium following injury. As such, it may enable us to dir-
ect the human adult EPDC fate in favor of cardiac
regeneration in the future.
Clinical relevance
Cardiac repair can be achieved by using inherent repair
mechanisms. Given its pivotal role during development
and cardiac injury, the epicardium is gaining recognition
as an endogenous cell source for cardiac repair. EPDCs
could interfere with several aspects of infarct healing.
First, the paracrine factors they secrete could prevent or
decrease the loss of contractile units. Second, EPDCs
play a role in scar formation and therefore, modulating
their behavior could ameliorate cardiac function. And third,
EPDCs could potentially contribute to vascularization and
myogenesis, both needed for cardiac recovery. To under-
stand the full potential of adult EPDCs, we require a de-
tailed understanding of the abilities of adult EPDCs to
contribute to cardiac repair, including the potential
these cells once had during development.
Additional file
Additional file 1: Figure S1. Isolation of human epicardium. (a) For
isolation of EPDCs, the epicardium was removed from the underlying
myocardium. (b) The isolated epicardial layer was positive for WT1 and
negative for the myocardial markers cTnT and βMHC. In addition, the
epicardial layer expressed, compared to myocardial tissue, low levels of
the smooth muscle marker αSMA. This data was representative for three
independent isolations, which all together showed the purity of the
isolated epicardial layer. Figure S2. Human fetal and adult EPDCs express
epicardium-related markers. (a) Summary of qRT-PCR analysis, indicating
expression levels of genes reportedly expressed in the epicardium or
EPDCs, showed that both fetal and adult EPDCs were positive for genes
investigated. (b) WT1, (c) TBX18, and (d) TCF21 protein were present
within the nucleus of both EPDC populations. Figure S3. Cultured
human fetal and adult EPDCs do not display markers attributed to other
heart-resident cell types. Gene expression was determined by qRT-PCR using
several heart-related markers for (a-b) cardiac fibroblasts, (c) endocardium,
(d) endothelial cells, (e) cardiac progenitor cells, (f) hematopoietic cells, and
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(g) mature cardiomyocytes. All data was shown as fold increase
compared to their corresponding control cell type or tissue (N.D.: not
detected). Figure S4. Fetal and adult EPDCs undergo EMT upon TGFβ
stimulation. Validation of EMT was determined by qRT-PCR showing
the downregulation of the epithelial genes ALDH1A2 and CDH1 in (a)
fetal and (b) adult EPDCs. In addition, POSTN and FN1 were upregulated
upon TGFβ stimulation in both (c) fetal and (d) adult EPDCs (data are
representative of at least three independent EMT experiments).
Figure S5. Migration and tube formation capacity of human EPDCs
and sEPDCs. Scratch assays revealed that TGFβ stimulation decreased
the migration rate of both (a) fetal and (b) adult sEPDCs. Furthermore,
the dotted line, representing the migration rate of fetal and adult
EPDCs, suggested that sEPDCs have an equal or even decreased ability
to migrate. In the tube formation assay, comparing fetal and adult
mesenchymal EPDCs, (c) adult sEPDCs had an increased ability to
assemble into a closed tubular network. (d) Matrigel-based tube formation
assays revealed that upon partial induction of EMT (untreated or TGFβ-
treated) adult EPDCs formed more tubes. #p < 0.05. Figure S6. Fetal EPDCs
are more prone to undergo EMT. (a) Upon removal of SB for a period of
4 days, WT1 protein was only withdrawn from the nucleus of fetal EPDCs.
(b) Upon TGFβ stimulation, fetal EPDCs underwent EMT at a faster
rate. This was shown by the occurrence of αSMA+ fibers in fetal cultures
already after 24 hours (day 1) of stimulation (scale bar: 50 μm). (c)
The epithelial-related factors, CDH1 and ANXA8, were increased in
adult EPDCs, (d) while the mesenchymal genes TCF21 and VIM were
upregulated in fetal EPDCs at baseline. #p < 0.05. (PDF 491 kb)
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